Angiogenic Exosome-Derived microRNAs: Emerging Roles in Cardiovascular Disease

J Cardiovasc Transl Res. 2021 Oct;14(5):824-840. doi: 10.1007/s12265-020-10082-9. Epub 2020 Oct 26.

Abstract

Angiogenesis is the process of growing endothelial capillary cells. Exosomes are extracellular vesicles that are rich in miRNAs. Studies have shown that exosomes can carry communication between cells and various tissues by delivering miRNAs to their target organs and cells. It has been repeatedly proven that miRNAs regulate the expression of growth factors and other proteins in endothelial cells through paracrine signalling and participate in the physiological and pathological processes of angiogenesis. In the diagnosis and treatment of diseases, exosome-derived microRNAs can play important roles as biomarkers and drug carriers. In this review, we introduce the characteristics of miRNAs and exosomes and their interactions. Then, we specifically summarize the exosome-derived miRNAs related to angiogenesis, and we discuss the potential uses of exosome-derived miRNAs for diagnosing and treating cardiovascular diseases. Graphical abstract.

Keywords: Angiogenesis; Biomarkers; Cardiovascular diseases; Endothelial cells; Exosomes; Therapeutic targets; microRNAs.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Cardiovascular Diseases* / diagnosis
  • Cardiovascular Diseases* / genetics
  • Cardiovascular Diseases* / therapy
  • Endothelial Cells
  • Exosomes* / genetics
  • Extracellular Vesicles*
  • Humans
  • MicroRNAs* / genetics

Substances

  • MicroRNAs